Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Contraceptive Injection Recalled
06/23/2022
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is voluntarily recalling a contraceptive injection due to concerns about product sterility.
Sun Pharmaceutical Industries Inc is voluntarily recalling a contraceptive injection due to concerns about product sterility.
Sun Pharmaceutical Industries...
06/23/2022
Pharmacy Learning Network
News
ALS Assessments Should Include Comprehensive Sensory Testing, Researchers Advise
06/23/2022
Jolynn Tumolo
Neuroimaging of patients with amyotrophic lateral sclerosis (ALS) showed degeneration of anatomical structures involved in somatosensory, visual, and auditory processing.
Neuroimaging of patients with amyotrophic lateral sclerosis (ALS) showed degeneration of anatomical structures involved in somatosensory, visual, and auditory processing.
Neuroimaging of patients with...
06/23/2022
Neurology
News
Hand Sanitizer Recalled Over Contaminants
06/23/2022
Jolynn Tumolo
Hand sanitizer distributed by Hand Cleansing Gel is under a Class II recall.
Hand sanitizer distributed by Hand Cleansing Gel is under a Class II recall.
Hand sanitizer distributed by...
06/23/2022
Pharmacy Learning Network
News
Asthma Medication Recalled
06/23/2022
Jolynn Tumolo
A Class II recall has been issued for a prescription anti-inflammatory medication used to treat patients with asthma.
A Class II recall has been issued for a prescription anti-inflammatory medication used to treat patients with asthma.
A Class II recall has been...
06/23/2022
Pharmacy Learning Network
News
Significant Intervention Opportunities Missed in Alcohol-Related Liver Disease Deaths
06/23/2022
Jolynn Tumolo
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care...
06/23/2022
Psych Congress Network
News
Multidisciplinary Model Optimizes Care of Patients With Type 2 Inflammatory Diseases
06/22/2022
Jolynn Tumolo
Researchers determined the best way to optimize care for patients with type 2 inflammatory diseases is a formalized multidisciplinary approach.
Researchers determined the best way to optimize care for patients with type 2 inflammatory diseases is a formalized multidisciplinary approach.
Researchers determined the best...
06/22/2022
First Report Managed Care
News
Walking Dysfunction Among Patients With COVID-19 Admitted to LTACHs
06/21/2022
Jolynn Tumolo
Study authors evaluated Six Minute Walk Test improvements in a national cohort of patients admitted to long-term acute care hospitals for severe COVID-19.
Study authors evaluated Six Minute Walk Test improvements in a national cohort of patients admitted to long-term acute care hospitals for severe COVID-19.
Study authors evaluated Six...
06/21/2022
First Report Managed Care
News
Distinct Gene Expression Signature Identified in Group of Patients With MDD
06/20/2022
Jolynn Tumolo
Patients with MDD who died by suicide had a gene expression signature distinct from other patients with MDD that included genes involved in stress response and polyamine metabolism, immune response, and telomere maintenance.
Patients with MDD who died by suicide had a gene expression signature distinct from other patients with MDD that included genes involved in stress response and polyamine metabolism, immune response, and telomere maintenance.
Patients with MDD who died by...
06/20/2022
Psych Congress Network
News
Medication Proves Effective for Treating Patients With Nonradiographic Axial Spondyloarthritis 
06/20/2022
Jolynn Tumolo
“This study demonstrated that secukinumab can be a viable option to treat the entire spectrum of axial spondyloarthritis (axSpA), that is, from early to late stage or from nonradiographic axSpA to radiographic axSpA,” wrote researchers.
“This study demonstrated that secukinumab can be a viable option to treat the entire spectrum of axial spondyloarthritis (axSpA), that is, from early to late stage or from nonradiographic axSpA to radiographic axSpA,” wrote researchers.
“This study demonstrated that...
06/20/2022
First Report Managed Care
News
Evaluating a New Treatment for Hypertrophic Obstructive Cardiomyopathy
06/17/2022
Jolynn Tumolo
A recent commentary outlined considerations for managed care pharmacists seeking to evaluate mavacamten for hypertrophic obstructive cardiomyopathy.
A recent commentary outlined considerations for managed care pharmacists seeking to evaluate mavacamten for hypertrophic obstructive cardiomyopathy.
A recent commentary outlined...
06/17/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use